We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.51B
1-Year Est. Return 164.17%
This Fund
S&P 500
This Quarter Est. Return
+49.89%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.26B
AUM Growth
+$210M
Cap. Flow
-$90.5M
Cap. Flow %
-7.19%
Top 10 Hldgs %
54.98%
Holding
68
New
14
Increased
7
Reduced
27
Closed
17

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$52.2M
2
PBYI icon
Puma Biotechnology
PBYI
+$33.5M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$32.1M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$28.5M
5
INCY icon
Incyte
INCY
+$24.9M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$56.1M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$26.6M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$25.7M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$25.1M
5
BKD icon
Brookdale Senior Living
BKD
+$23.9M

Sector Composition

Rank Sector Weight
1 Healthcare 92.15%
2 Communication Services 1.37%
3 Consumer Staples 0.51%
4 Technology 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKD icon
51
Brookdale Senior Living
BKD
$3.46B
– –
-1,545,331
Closed -$23.9M
BMRN icon
52
BioMarin Pharmaceuticals
BMRN
$11.4B
– –
-322,394
Closed -$25.1M
EHTH icon
53
eHealth
EHTH
$42.9M
– –
-426,242
Closed -$5.98M
SNDX icon
54
Syndax Pharmaceuticals
SNDX
$1.88B
– –
-250,830
Closed -$2.47M
XBI icon
55
State Street SPDR S&P Biotech ETF
XBI
$10.2B
– –
-490,900
Closed -$26.6M
SIOX
56
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-3,125
Closed -$321K
LHCG
57
DELISTED
LHC Group LLC
LHCG
– –
-5,000
Closed -$216K
CFMS
58
DELISTED
Conformis, Inc. Common Stock
CFMS
– –
-41,913
Closed -$7.36M
ARA
59
DELISTED
American Renal Associates Holdings, Inc
ARA
– –
-149,900
Closed -$4.34M
AET
60
DELISTED
Aetna Inc
AET
– –
-183,225
Closed -$22.4M
EVHC
61
DELISTED
Envision Healthcare Holdings Inc
EVHC
– –
-96,499
Closed -$7.33M
PMC
62
DELISTED
PharMerica Corporation
PMC
– –
-263,862
Closed -$6.51M
ADPT
63
DELISTED
Adeptus Health Inc
ADPT
– –
-163,474
Closed -$8.45M
TMH
64
DELISTED
Team Health Holdings Inc
TMH
– –
-5,000
Closed -$203K
PGND
65
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
– –
-198,214
Closed -$7.8M
HTWR
66
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-405,497
Closed -$23.4M
MDVN
67
DELISTED
MEDIVATION, INC.
MDVN
– –
-929,529
Closed -$56.1M
1 2
3

Similar funds

KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Redmile Group's Q3 2016 Portfolio in Review

As of Q3 2016, Redmile Group held 68 positions worth $1.26B, up 20% from $1.05B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Redmile Group withdrew a net $90.5M in Q3 2016, closing 17 positions and reducing 27 holdings. Its most notable exit was MEDIVATION, INC., an estimated $56.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 73% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, Redmile Group opened a new position in GW Pharmaceuticals Plc American Depositary Shares worth $72.5M.

  • Redmile Group's largest Q3 2016 buy was GW Pharmaceuticals Plc American Depositary Shares: 545,922 shares worth $72.5M.
  • Redmile Group added most to Incyte in Q3 2016, an estimated $24.9M increase.
  • Redmile Group's biggest Q3 2016 reduction was Intra-Cellular Therapies Inc., cutting an estimated $25.7M.
  • Redmile Group fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $56.1M.
  • Redmile Group's ten largest holdings make up 55% of its $1.26B portfolio in Q3 2016.
  • Redmile Group opened 14 new positions and closed 17 in Q3 2016.
  • Redmile Group's portfolio value rose 20% quarter-over-quarter to $1.26B.

Based on Redmile Group's 13F filing for Q3 2016, filed 15 Nov 2016.